Oral Sodium Phosphate (OSP) Products for Bowel Cleansing (marketed as Visicol and OsmoPrep, and oral sodium phosphate products available without a prescription)

more+
less-

FDA has become aware of reports of acute phosphate nephropathy, a type of acute kidney injury, associated

with the use of oral sodium phosphate products (OSP) for bowel cleansing prior to colonoscopy or other

procedures. These products include the prescription products, Visicol and OsmoPrep, and OSPs available

over-the-counter without a prescription as laxatives (e.g., Fleet Phospho-soda). In some cases when used for

bowel cleansing, these serious adverse events have occurred in patients without identifiable factors that would

put them at risk for developing acute kidney injury.

LOADING PDF: If there are any problems, click here to download the file.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Hissey Kientz LLP | Attorney Advertising

Written by:

more+
less-

Hissey Kientz LLP on:

JD Supra Readers' Choice 2016 Awards
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×
Loading...
×
×